3 terminated. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 3 |
Follow Hemolysis: new trials by email Literature Review of Hemolysis trials Research Report on Hemolysis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of the Oral Factor D (FD) Inhibitor ALXN2050 in PNH Patients as Monotherapy ALXN2050 - Paroxysmal Nocturnal Hemoglobinuria (PNH) | Phase 2 | Terminated | Alexion Pharmaceuticals, Inc. | 29 | 2019-12-16 | 2024-11-20 |
| Study of Albumin to Reduce Inflammation Following Surgery 20% Human albumin solution, Gelofusin - Systemic Inflammatory Response Syndrome, Cardiopulmonary Bypass | Phase 2 | Terminated | Imperial College London | 232 | 2008-12-01 | 2014-05-28 |
| A Safety and Efficacy Trial of Stannsoporfin in Neonates With Hyperbilirubinemia Stannsoporfin, Placebo, PhotoTherapy (as needed) - Hyperbilirubinemia, Neonatal | Phase 2 | Terminated | InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company | 58 | 2008-08-01 | 2019-10-30 |
Hemoglobinuria, Paroxysmal (1) · Hyperbilirubinemia, Neonatal (1) · Systemic Inflammatory Response Syndrome (1)
Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Anemia (1) · Anemia, Hemolytic (1) · Bone Marrow Diseases (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Hyperbilirubinemia (1) · Infant, Newborn, Diseases (1) · Inflammation (1) · Myelodysplastic Syndromes (1) · Shock (1)
Phototherapy (1) · Sodium Chloride (1) · succinylated gelatin (1) · tin mesoporphyrin (1)
Alexion Pharmaceuticals, Inc. (1) · Imperial College London (1) · InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company (1)
Spain (2) · United Kingdom (2) · Canada (1) · Italy (1) · New Zealand (1) · Poland (1) · South Korea (1) · Turkey (Türkiye) (1) · Ukraine (1) · United States (1)
Mark J Griffiths (1)
2009 (1), 2019 (1)